drugset / Trial / NCT04825613
"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis"
Summary
This Individual Patient Expanded Access IND has been created as requested by an 83-year-old man who suffers Primary Lateral Sclerosis and for which the drugs currently approved are not providing an improvement over the progression of this disease.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HB-adMSCs | Cell therapy | 2e+08 cells | — |